Please assess the completion status of the following clinical trial:

Trial Title: Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. patients aged 18-65 years~2. Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of major depressive disorder~3. competent and willing to give informed consent~4. taking the current antidepressant medication for a minimum of 4 weeks prior to baseline~5. the current episode of depression has failed to remit with at least two courses of antidepressant treatment (one of which is the current course)~6. able to take oral medication~7. if female, willing to use adequate contraceptive precautions and to have monthly pregnancy tests.~Exclusion Criteria:~1. relevant medical illness (renal, hepatic, cardiac, serious dermatological disorders such as exfoliative dermatitis, systemic lupus erythematosis)~2. prior history of intolerance to any of the tetracyclines~3. concomitant penicillin therapy~4. concomitant anticoagulant therapy~5. presence of a seizure disorder~6. currently taking valproic acid~7. any change of psychotropic medications within the previous 4 weeks~8. diagnosis of substance abuse (except nicotine or caffeine) or dependence within the last 3 months according to DSM-IV criteria~9. pregnant or breast-feeding~10. presence of primary psychotic disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Minocycline (Type: EXPERIMENTAL): Minocycline 200mg perday
- comparison group with placebo (Type: PLACEBO_COMPARATOR): Placebo provide

Based on this trial design, predict the completion outcome and termination type (if applicable).